Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 12, 2009, Pages 4822-4827

  Sasportas, Laura S ^a   Kasmieh, Randa ^a   Wakimoto, Hiroaki ^a   Hingtgen, Shawn ^a   Van De Water, Jeroen A J M ^a   Mohapatra, Gayatry ^a   Figueiredo, Jose Luiz ^a   Martuza, Robert L ^a   Weissleder, Ralph ^a,b   Shah, Khalid ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Gliomas; In vivo imaging; TRAIL

Indexed keywords

CASPASE; CD133 ANTIGEN; LENTIVIRUS VECTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOENGINEERING; CANCER CELL CULTURE; CANCER INVASION; CANCER THERAPY; CELL MIGRATION; CELL THERAPY; CLINICAL ASSESSMENT; DIAGNOSTIC IMAGING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT; ANIMAL; BYSTANDER EFFECT; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; DRUG SCREENING; GENETIC ENGINEERING; GENETIC TRANSDUCTION; GLIOMA; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE;

MUS;

ANIMALS; BYSTANDER EFFECT; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; GENETIC ENGINEERING; GLIOMA; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSDUCTION, GENETIC; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 63849148548     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0806647106     Document Type: Article

References (47)

1. Jiang Y, et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
2. Mareschi K, et al. (2006) Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem 97:744-754.
3. Aboody KS, Najbauer J, Danks MK (2008) Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 15:739-752.
4. Corsten MF, et al. (2007) MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67:8994-9000.
5. Pereboeva L, Komarova S, Mikheeva G, Krasnykh V, Curiel DT (2003) Approaches to utilize mesenchymal progenitor cells as cellular vehicles. Stem Cells 21:389-404.
6. Sathornsumetee S, Rich JN (2006) New approaches to primary brain tumor treatment. Anticancer Drugs 17:1003-1016.
7. Calabrese C, et al. (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69-82.
8. Singh SK, et al. (2004) Identification of human brain tumour initiating cells. Nature 432:396-401.
9. Nakamizo A, et al. (2005) Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307-3318.
10. Miletic H, et al. (2007) Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther 15:1373-1381.
11. Nakamura K, et al. (2004) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11:1155-1164.
12. Hamada H, et al. (2005) Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 96:149-156.
13. Shah K, et al. (2008) Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J Neurosci 28:4406-4413.
14. Shah K, Tung CH, Yang K, Weissleder R, Breake field XO (2004) Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy. Cancer Res 64:3236 -3242.
15. Karnoub AE, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557-563.
16. Lu Y, et al. (2008) The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther 7:245-251.
17. Yu JM,Jun ES,Bae YC,JungJS(2008)Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev17:463-473.
18. Czyz J, Irmer U, Schulz G, Mindermann A, Hulser DF (2000) Gap-junctional coupling measured by flow cytometry. Exp Cell Res 255:40-46.
19. Verhaegent M, Christopoulos TK (2002) Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. Anal Chem 74:4378-4385.
20. Lee K, et al. (2001) Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Mol Ther 3:857-866.
21. Van Damme A, et al. (2006) Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells 24:896-907.
22. Chan J, et al. (2005)Human fetal mesenchymal stem cell sasvehicles for gene delivery. Stem Cells 23:93-102.
23. Maeurer MJ, et al. (1995) Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes. Cancer Immunol Immunother 41:111-121.
24. Vieweg J, Su Z, Dahm P, Kusmartsev S (2007) Reversal of tumor-mediated immunosup- pression. Clin Cancer Res 13(suppl):727s-732s.
25. Zou W(2006)RegulatoryTcells, tumourimmunity and immunotherapy. Nat RevImmunol 6:295-307.
26. Ehtesham M, et al. (2002) Induction of glioblastoma apoptosis using neural stem cell- mediated delivery of tumor necrosisfactor-related apoptosis-inducing ligand. Cancer Res 62:7170-7174.
27. Imitola J, et al. (2004) Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 101:18117-18122.
28. Son BR, et al. (2006)Migration of bone marrow and cord blood mesenchymal stem cellsin vitro is regulated by stromal- derived factor-1-CXCR4and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 24:1254-1264.
29. Heese O, Disko A, Zirkel D, Westphal M, Lamszus K (2005) Neural stem cell migration toward gliomas in vitro. Neurol Oncol 7:476-484.
30. SchmidtNO, et al. (2005) Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 7:623-629.
31. Widera D, et al. (2004) MCP-1 induces migration of adult neural stem cells. Eur J Cell Biol 83:381-387.
32. PalumboR, et al. (2007)Cellsmigrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation. J Cell Biol 179:33-40.
33. Von Luttichau I, et al. (2005) Human adultCD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10butnot CXCR4. Stem Cells Dev 14:329-336.
34. Birnbaum T, et al. (2007) Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J Neurooncol 83:241-247.
35. Stagg J, Lejeune L, Paquin A, Galipeau J (2004) Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy. Hum Gene Ther 15:597-608.
36. Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C (2007) Adipose tissue- derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res67:6304-6313.
37. Sonabend AM, et al. (2008) Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells 26:831-841.
38. Almasan A, Ashkenazi A(2003) Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14:337-348.
39. Germano IM, Uzzaman M, Benveniste RJ, Zaurova M, Keller G (2006) Apoptosisin human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis- inducing ligand. J Neurosurg105:88-95.
40. Panner A, James CD, Berger MS, Pieper RO (2005) mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol 25:8809-8823.
41. Griffith TS, Anderson RD, Davidson BL, Williams RD, Ratliff TL. (2000) Adenoviral- mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol 165:2886-2894.
42. Kagawa S, et al. (2001) Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis- inducing ligand (TRAIL) gene. Cancer Res 61:3330-3338.
43. Shah K, et al. (2005) Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol 57:34-41.
44. Dirks PB (2005) Brain tumor stem cells. Biol Blood Marrow Transplant 11:12-13.
45. Shah K, Tang Y, Breakefield X, Weissleder R (2003) Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 22:6865-6872.
46. Kock N, Kasmieh R, Weissleder R, Shah K (2007) Tumor therapy mediated by lentiviral expression of shBcl-2 and S- TRAIL. Neoplasia 9:435-442.
47. Wakimoto H, et al. (2009) Human glioblastoma-derived cancer stem cells: Establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res, in press.